mouse insulin like growth factor protein 4 Search Results


N/A
Mouse Insulin-Like Growth Factor Binding Protein 4 Chemiluminescent Immunoassay Kit from Innovative Research is a highly sensitive Chemiluminescent Immunoassay for meauring Insulin-Like Growth Factor Binding Protein 4 in biofluid samples, such as serum, plasma and
  Buy from Supplier

N/A
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their
  Buy from Supplier

93
ABclonal Biotechnology mouse igfbp4
Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
Mouse Igfbp4, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin+Like+Growth+Factor+Binding+Protein+4+ELISA+Kit/pmc12853802-307-8-11
Average 93 stars, based on 1 article reviews
mouse igfbp4 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Cusabio mouse insulin like growth factor protein 4
Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
Mouse Insulin Like Growth Factor Protein 4, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin-like+growth+factor+binding+protein+4%2CIGFBP-4+ELISA+kit/pmc12348007-214-27-36
Average 93 stars, based on 1 article reviews
mouse insulin like growth factor protein 4 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

N/A
The ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of samples in cell culture supernatant, serum, plasma (EDTA, citrate, heparin).
  Buy from Supplier


N/A
Enzyme Immunoassay for the Quantitative Determination of Mouse Insulin Like Growth Factor Binding Protein 4, IGFBP4 in serum, plasma, tissues and other biological samples
  Buy from Supplier

N/A
Mouse Insulin Like Growth Factor Binding Protein 4 ELISA Kit from Innovative Research is intended for the quantitative determination of Mouse Insulin Like Growth Factor Binding Protein 4 in biofluid samples, such as serum, plasma,
  Buy from Supplier


Image Search Results


Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

Journal: Journal of Nanobiotechnology

Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

doi: 10.1186/s12951-025-03943-5

Figure Lengend Snippet: Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

Techniques: Electrophoresis, Derivative Assay

AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

Journal: Journal of Nanobiotechnology

Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

doi: 10.1186/s12951-025-03943-5

Figure Lengend Snippet: AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

Techniques: Control, Clinical Proteomics, Enzyme-linked Immunosorbent Assay